#Nordisk

Cellular Intelligence just acquired the rights to an experimental Parkinson’s cell therapy from Novo Nordisk.

Novo Nordisk A/S saw a 40% surge in sales of its diabetes and weight-loss drugs in India last month, after steep price cuts boosted demand for its branded treatments even as generic GLP-1 therapies flood the market.

From Google News - World: Novo Nordisk CEO says the drugmaker is more active than ever in seeking out deals - CNBC

Novo Nordisk A/S (NOVO:CA) Q1 2026 Earnings Call May 6, 2026 7:00 AM EDTCompany ParticipantsMichael Novod - Senior VP & Head of Investor RelationsMaziar...

Novo Nordisk CEO Mike Doustdar says the Ozempic and Wegovy maker is looking for deals more than ever before.

From Independent RSS Feed: Wegovy maker Novo Nordisk boosted by successful weight loss pill launch